[1]王芬 陈复琼 刘喆隆 周新荣.抗磷脂抗体综合征致Addison病1例报道[J].国际内分泌代谢杂志,2020,40(03):215-216.[doi:10.3760/cma.j.issn.1673-4157.2020.03.016]
 Wang Fen,Chen Fuqiong,Liu Zhelong,et al.A case of Addison's disease caused by antiphospholipid syndrome[J].International Journal of Endocrinology and Metabolism,2020,40(03):215-216.[doi:10.3760/cma.j.issn.1673-4157.2020.03.016]
点击复制

抗磷脂抗体综合征致Addison病1例报道()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
40
期数:
2020年03期
页码:
215-216
栏目:
病例报告
出版日期:
2020-05-20

文章信息/Info

Title:
A case of Addison's disease caused by antiphospholipid syndrome
作者:
王芬 陈复琼 刘喆隆 周新荣
华中科技大学同济医学院附属同济医院内分泌科,武汉 430030
Author(s):
Wang Fen Chen Fuqiong Liu Zhelong Zhou Xinrong
Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
DOI:
10.3760/cma.j.issn.1673-4157.2020.03.016

参考文献/References:

[1] Garcia D,Erkan D.Diagnosis and management of the antiphospholipid syndrome[J].N Engl J Med,2018,378(21):2010-2021.DOI:10.1056/NEJMra1705454.
[2] Miyakis S,Lockshin MD,Atsumi T,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J].J Thromb Haemost,2006,4(2):295-306.DOI:10.1111/j.1538-7836.2006.01753.x.
[3] 赵久良,孙伊多,张遥,等.原发性抗磷脂综合征107例临床特点及血栓事件危险因素分析[J]. 中华内科杂志,2016,55(5):386-391.DOI:10.3760/cma.j.issn.0578-1426.2016.05.011.
[4] Ramon I,Mathian A,Bachelot A,et al.Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome:long-term outcome of 16 patients[J].J Clin Endocrinol Metab,2013,98(8):3179-3189.DOI:10.1210/jc.2012-4300.
[5] Lee KH,Lee H,Lee CH,et al.Adrenal insufficiency in systematic lupus erythematosus(SLE)and antiphospholipid syndrome(APS):a systematic review[J].Autoimmun Rev,2019,18(1):1-8.DOI:10.1016/j.autrev.2018.06.014.
[6] Dickstein G,Shechner C,Nicholson WE,et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggestednew sensitive low dose test[J].J Clin Endocrinol Metab,1991,72(4):773-778.DOI:10.1210/jcem-72-4-773.
[7] Erturk E,Jaffe CA,Barkan AL.Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemiatest[J].J Clin Endocrinol Metab,1998,83(7):2350-2354.DOI:10.1210/jcem.83.7.4980.
[8] Charmandari E,Nicolaides NC,Chrousos GP.Adrenal insufficiency[J].Lancet,2014,383(9935):2152-2167.DOI:10.1016/S0140-6736(13)61684-0.
[9] Oelkers W,Diederich S,Bähr V. Diagnosis and therapy surveillance in Addison's disease:rapid adrenocorticotropin(ACTH)testand measurement of plasma ACTH, renin activity, and aldosterone[J].J Clin Endocrinol Metab,1992,75(1):259-264. DOI:10.1210/jcem.75.1.1320051.
[10] 李延兵,胡国亮,姚斌,等.慢性肾上腺皮质功能减退症70例临床分析[J]. 新医学,2001,32(4):207-209.DOI:10.3969/j.issn.0253-9802.2001.04.007.
[11] Zelissen PM,Bast EJ, Croughs RJ.Associated autoimmunity in Addison's disease[J].J Autoimmun,1995,8(1):121-130.DOI:10.1006/jaut.1995.0009.
[12] Mujic F,Cuadrado MJ,Lloyd M,et al.Primary antiphospholipid syndrome evolving into systemic lupus erythematosus[J].J Rheumatol,1995,22(8):1589-1592.
[13] Veres K,Szodoray P,Szekanecz Z,et al.Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome[J].Lupus, 2010,19(13):1520-1526.DOI:10.1177/0961203310374336.
[14] Cervera R,Serrano R,Pons-Estel GJ,et al.Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients[J].Ann Rheum Dis,2015,74(6):1011-1018.DOI:10.1136/annrheumdis-2013-204838.

备注/Memo

备注/Memo:
通信作者:周新荣,Email:zhouxinrong8@126.com
Corresponding author: Zhou Xinrong, Email: zhouxinrong8@126.com
更新日期/Last Update: 2020-05-20